GO-Y022-treated gastric tumor cells demonstrated increased glycolysis and ATP production compared with DMSO-treated gastric tumor cells, which contributed to the production of many liquid factors, including TGF-β and L-lactate. This evidence concerns the gene TGFB1 and gastric neoplasm.